Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Insulin Response in Patients with Liver Cirrhosis Before and After Liver Transplant

Studies blood sugar and insulin response in adults with liver cirrhosis before and after transplant.

Plain-language title generated from the registry record
Registry title: Cirrhosis, Effects of TRAnsplantation and Diabetes

Key facts

Where
Milan, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT02038517, who can take part

Where in Italy

  • Endocrinology and Diabetes Unit, Fondazione IRCCS Cà Granda - Ospedale Maggiore PoliclinicoMilan, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Trial code
NCT02038517
Record updated
1 March 2016
Original description
This observational study is aimed at assessing insulin secretion and sensitivity by the use of a mathematical modeling from oral glucose tolerance test in subjects with liver cirrhosis undergoing orthotopic liver transplantation (OLT), before and at various time points after OLT.Read full original descriptionShow less

Insulin Secretion and Sensitivity in Subjects With Liver Cirrhosis Undergoing Orthotopic Liver Transplantation (OLT): Pre- and Post-OLT Analysis

This observational study is aimed at assessing insulin secretion and sensitivity by the use of a mathematical modeling from oral glucose tolerance test in subjects with liver cirrhosis undergoing orthotopic liver transplantation (OLT), before and at various time points after OLT.

Inclusion: Subjects with end-stage liver cirrhosis in waiting list for orthotopic liver transplantation at the Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico, Milan, Italy.

Exclusion: Known diabetes; Cystic fibrosis; Pregnancy.

ClinicalTrials.gov NCT02038517